KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Payables: 2009-2025

Historic Payables for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $616.0 million.

  • Bausch Health Companies' Payables fell 7.65% to $616.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 5.95%. This contributed to the annual value of $589.0 million for FY2024, which is 18.08% down from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Payables is $616.0 million, which was down 1.75% from $627.0 million recorded in Q2 2025.
  • Bausch Health Companies' Payables' 5-year high stood at $719.0 million during Q4 2023, with a 5-year trough of $342.0 million in Q1 2021.
  • Over the past 3 years, Bausch Health Companies' median Payables value was $616.0 million (recorded in 2025), while the average stood at $609.5 million.
  • Its Payables has fluctuated over the past 5 years, first fell by 22.97% in 2021, then skyrocketed by 38.00% in 2023.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Payables stood at $407.0 million in 2021, then climbed by 28.01% to $521.0 million in 2022, then skyrocketed by 38.00% to $719.0 million in 2023, then dropped by 18.08% to $589.0 million in 2024, then decreased by 7.65% to $616.0 million in 2025.
  • Its Payables stands at $616.0 million for Q3 2025, versus $627.0 million for Q2 2025 and $620.0 million for Q1 2025.